GIM
IMMU

Granahan Investment Management’s Immunomedics Inc IMMU Stock Holding History

Granahan Investment Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-179,141
Closed -$15.2M – 208
2020
Q3 		$15.2M Sell
179,141
-375,231
-68% -$19M 0.52% 55
2020
Q2 		$19.6M Buy
554,372
+34,075
+7% +$996K 0.71% 38
2020
Q1 		$7.01M Buy
520,297
+89,706
+21% +$1.51M 0.38% 73
2019
Q4 		$9.11M Sell
430,591
-105,697
-20% -$1.86M 0.42% 70
2019
Q3 		$7.11M Buy
536,288
+45,787
+9% +$673K 0.39% 71
2019
Q2 		$6.8M Buy
490,501
+162,340
+49% +$2.44M 0.34% 74
2019
Q1 		$6.3M Sell
328,161
-32,710
-9% -$527K 0.34% 79
2018
Q4 		$5.15M Sell
360,871
-8,150
-2% -$162K 0.36% 79
2018
Q3 		$7.69M Buy
369,021
+13,100
+4% +$310K 0.42% 77
2018
Q2 		$8.43M Buy
355,921
+216,421
+155% +$4.35M 0.51% 65
2018
Q1 		$2.04M Hold
139,500
– – 0.15% 147
2017
Q4 		$2.25M Buy
+139,500
New +$1.65M 0.18% 140

Granahan Investment Management's IMMU Position: Q4 2020 in Review

Granahan Investment Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 179,141 shares — an estimated $15.2M sold.

Granahan Investment Management first reported a position in IMMU in Q4 2017 and held it in 12 quarters. The position peaked at $19.6M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Granahan Investment Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Granahan Investment Management sold 179,141 Immunomedics Inc shares in Q4 2020, an estimated $15.2M.
  • Granahan Investment Management first reported a position in Immunomedics Inc in Q4 2017 and held it in 12 quarters.
  • Granahan Investment Management's Immunomedics Inc position peaked at $19.6M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Granahan Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.